I really don't want to be a doctor

Chapter 160

"Xiao Ran, help Teacher Tan push a patient into the cath lab!"

"Xiao Ran, the patient in bed 18 needs to change the medicine, please help me change it."

After staying in the cardiology intensive care unit for a month, most of the doctors and nurses in the intensive care unit knew Jing Xiaoran.

"Xiao Jing, take the ultrasound and go to see the 32-bed patient and evaluate the state of the heart."

"Xiao Jing, the doctor ordered you to tidy up the 8-bed patient!"

In Teacher Zhu Zhu's group, Jing Xiaoran is definitely a student who is handy.

"Xiao Ran, remember to do a blood gas analysis for me."

Nurse Guan Xin would always ask Jing Xiaoran for help, because Jing Xiaoran usually would not refuse, and she was also the only intern who could do blood gas analysis.

"Squad leader, teach me how to write this course of disease."

For Hong Sheng, Jing Xiaoran is positioned as a "bug" level existence, no matter what problems he encounters, he will definitely be able to solve them by looking for Jing Xiaoran.

Jing Xiaoran was very tired in the intensive care unit of the cardiology department, but it was the most fulfilling time since he was reborn.

It may be that he has returned to his own job, and the whole person's spirit is different.

After a busy day, I went back to my bedroom.

"Squad leader, I have finished all the papers you asked me to collect!"

Hong Sheng handed Jing Xiaoran an A4 paper filled with thesis topics.

"In the past year, "Tumor Biology" has a total of more than 40 SCI papers from Chinese scholars, and three of them have published two or more papers!"

Jing Xiaoran took the A4 paper, nodded in satisfaction and said, "Good job."

There are only forty papers by Chinese scholars, not many, but this kind of result is within his expectation, because it will be some time before the exposure of the previous life.

In addition, these more than 40 papers cannot all be faked, and investigations are still needed.

"Squad leader, what shall we do next?" Hong Sheng asked curiously.

"You'll know soon." Jing Xiaoran smiled, he had already thought of how to obtain the peer-reviewed information of "Tumor Biology".

……

American Pfizer.

Hamer, who is in charge of the European and American regions, has been proud of his success in the past two years, and his position in Pfizer may rise further at any time.

In the final analysis, this is entirely due to a patent that Hammer bought out two years ago - a new oral anticoagulant, and he completed the buyout of the entire patent at the smallest cost.

This time, Hammer's successful case even became a teaching model for Pfizer.

"Morning, Mr. Hammer~"

"Mr. Hammer, you are so handsome today!"

"Mr. Hammer, here is a buyout plan for the latest drugs. Please take a look if you have time."

Every morning, as soon as Hammer arrives at the office, the employees of the company will show affection to him intentionally or unconsciously.

"There should be a meeting later." Hamer said to the secretary beside him.

"Yes, Mr. Hammer."

The long-legged secretary with blond hair and blue eyes nodded slightly, showing a charming smile to Hamer.

"Well, the content of today's meeting is very important, about the determination of the new drug acquisition plan. Let everyone come to the meeting on time, I don't want to see anyone late!" Hammer ordered.

"Mr. Hammer, don't worry, I will notify the supervisors below." The long-legged secretary replied, "Make sure no one is late."

"Ding ding..." At this moment, Hamed's cell phone rang.

Hammer frowned. It was his personal cell phone that rang, and most people would not call at this time.

"Hello, Mr. Hammer?"

I heard the Chinese language coming from the phone.

The expression on Hamer's face was stunned for a moment, and then it was full of surprises.

"Mr. Jing, is that you?"

"En." Jing Xiaoran said.

"Your laboratory will be completed in one month, and we will purchase all kinds of laboratory instruments and equipment for you according to your requirements."

Hammer just like to report the work progress to his superiors, nodding and bowing while holding the phone.

Although the secretary at the side couldn't understand Chinese, he was also surprised when he saw this behavior of Hamer.

According to Hamer's current status, there shouldn't be such a reaction!
Could this be a call from someone from Pfizer, but it's not quite right, because there are no foreigners in power at the headquarters.

"Mr. Hammer, don't worry!" Jing Xiaoran said helplessly when he heard what Hammer said, "I'm not here this time to tell you about the laboratory."

"It's not a laboratory?" Hammer was puzzled, he and Jing Xiaoran didn't seem to have any other intersections other than this relationship.

"Mr. Hammer, I actually want you to do me a favor." Jing Xiaoran said.

"You said you said it." Hammer immediately replied, "I, as well as Pfizer, are very happy to help you."

The long-legged secretary's eyes widened, and she felt that Hamer's expression and language were more respectful than before.

"Do you know the editors of the "Tumor Biology" journal? I want their peer-reviewed information recommended by the authors of the papers in the last year."

Jing Xiaoran's voice slowly came out of the microphone, Hammer was taken aback for a moment, and then laughed, "Mr. Jing, that's what it is? It's a piece of cake! I can send all peer review information to you!"

"Then I can't thank you very much, Mr. Hammer."

Jing Xiaoran didn't expect it to be so smooth. He originally thought that Pfizer had this relationship, but it might be a bit difficult in practice.

"Well, Mr. Jing, I want to ask about new oral anticoagulant drugs." Hammer asked suddenly.

"what happened?"

Hammer cleared his throat and said, "First, the new oral anticoagulant drug is about to enter phase 3 clinical trials. I would like to ask you, have you thought about where this drug is being clinically studied in Huaxia?"

"Second, it is still about new oral anticoagulants. We have gone through the previous phases of clinical trials, and the overall effect is very good. But we have not found antagonists of new oral drugs. The anticoagulants commonly used in clinical practice now ——Warfarin, this has an antagonist Vk; but the new oral anticoagulant does not have an antagonist, so what should we do if an overdose occurs clinically and causes massive bleeding?"

After hearing Hammer's words, Jing Xiaoran suddenly admired Pfizer.

Pfizer Hongsheng considers the problem from a comprehensive perspective. Before the new oral anticoagulant drugs are on the market, they can think of the problem of antagonists in advance.

"Mr. Hammer, I have chosen the clinical trial site for the new oral anticoagulant drug, and I will send you the specific hospital later. As for the antagonist issue, I already have some ideas." Jing Xiaoran said, " But I can't verify it until the laboratory is completed."

"Really? That's really great." Hammer smiled, "I will try my best to remind you about the matter in the laboratory! I will give you the information about the peer review you mentioned in the afternoon reply."

"Ok!"

After hanging up the phone, Hammer had a bright smile on his face.

"Put off today's meeting until tomorrow!" Hamer said to the secretary beside him.

"Yes, but didn't you just say that you have something important to announce?" the long-legged secretary asked.

"I have more important things to do!"

Hammer smiled, and then walked out of his office.

(End of this chapter)